Our pipeline

澳门葡京赌博游戏有一个令人兴奋和平衡的管道,以伟大的科学为基础.

Home / Our therapy areas / Our pipeline

Latest quarterly updates

澳门葡京赌博游戏的产品线在临床开发的不同阶段形成了强大的研究性治疗组合.


172

projects in our pipeline

14

new molecular entities in our late-stage pipeline

1

new molecular entity under review

第三阶段/LCM项目:指的是第二/第三阶段的关键资产, 或者已经提交监管部门批准的, 并且可能包括现在在一个或多个主要市场推出的资产(在所有适用的主要市场推出时删除).


Oncology (as of 28 July 2023)

Phase I

Phase I

Phase II

Phase II

Phase III

Phase III

LCM Projects

LCM Projects

心血管、肾脏及新陈代谢(截至2023年7月28日)

Phase I

Phase I

Phase II

Phase II

Phase III

Phase III

LCM Projects

LCM Projects

Respiratory & Immunology (as of 28 July 2023)

Phase I

Phase I

Phase II

Phase II

Phase III

Phase III

LCM Projects

LCM Projects

Rare Disease (as of 28 July 2023)

Phase I

Phase I

Phase II

Phase II

Phase III

Phase III

LCM Projects

LCM Projects

Vaccine & Immune therapies (as of 28 July 2023)

Phase I

Phase I

Phase II

Phase II

Phase III

Phase III

LCM Projects

LCM Projects

Other (as of 28 July 2023)

Phase I

Phase I

Phase II

Phase II

Phase III

Phase III

LCM Projects

LCM Projects

Removed since last quarter

Veeva ID: Z4-57208
Date of preparation: August 2023